State Medicaid P&T Committee Meeting - Revision 5
This is a Notice Revision
You are currently viewing a revision of a notice. This is a previous copy of a notice that has been published more recently. To view the current version of this notice, click here.
Please Note: Only the files that were associated to this version are included in the Download Attachments section. If that section does not display, all attachments were removed from this version of the notice.
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Pharmacy and Therapeutics Committee
Notice Information
- Notice Title
- State Medicaid P&T Committee Meeting
- Notice Tags
- Medicaid, Pharmacies
- Notice Type(s)
- Meeting
- Event Start Date & Time
- May 15, 2025 07:00 AM
- Event End Date & Time
- May 15, 2025 08:45 AM
- Event Deadline Date & Time
- 05/15/25 08:45 AM
- Description/Agenda
- Pharmacy & Therapeutics Committee Meeting Agenda Thursday, May 15, 2025 7:00 a.m. to 8:45 a.m. Google Meet joining information Video call link: mee.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the P&T Committee may contact Ngan Huynh at (nganhuynh@utah.gov) before the meeting or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Susan Siegfried, MD, Chair a) Announce Quorum 2) Welcome and Introductions - Susan Siegfried, MD, Chair a) Review and Approval of Minutes b) Housekeeping 3) DUR Board Update - Luis Moreno, PharmD 4) Annual Open Public Meeting Training - Tony Patterson, Assistant Attorney General 5) Review a) ALK, MET, AND RET Selective Inhibitors For Approved Oncologic Disorders - Valerie Gonzales, PharmD i) alectinib (ALECENSA), brigatinib (ALUNBRIG), capmatinib (TABRECTA), certanib (ZYKADIA), crizotinib (XALKORI), ensartib (ENSACOVETM), lorlatinib (LORBRENA), praalsetinib (GAVRETO), selpercatinib (RETEVMO), tepotinib (TEPMETKO) b) Committee Discussion/Questions c) Committee Action 6) Next Meeting Thursday, September 18, 2025 - Botulinum Toxins 7) Adjourned - Susan Siegfried, MD, Chair
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Ngan Huynh at 801-538-6155. Tentative Upcoming Pharmacy & Therapeutics Committee Schedule **Please note: all topics are tentative and subject to change** Month 18 Sept 2025 Topic Botulinium Toxins Agents Botox, Dyspart, Xeomin The foundation documents used for most reviews are prepared by the University of Utah, College of Pharmacy, and are posted on the P&T Committee website after the meeting. Manufacturers wishing to submit any additional materials they would like reviewed as part of the process to: Dr. Joanne LaFleur College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled so that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be reviewed at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible), unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search.
- Notice of Electronic or Telephone Participation
- Video call link: mee.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Ngan Huynh
- Contact Email
- nganhuynh@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- May 07, 2025 10:36 AM
- Notice Last Edited On
- May 07, 2025 11:39 AM
- Deadline Date
- May 15, 2025 08:45 AM